Novartis provides healthcare solutions that address the evolving needs of patients and societies through its innovative medicines, cost-saving generics, vaccines, diagnostics and consumer health products that include eye care and self-medication. In 2009, the group achieved net sales of $44.3 billion USD and invested $7.5 billion USD in R&D to tackle diseases with high unmet medical need.
Novartis supports healthy aging as a key policy objective in managing demographic change. We are committed to work in partnership and provide healthcare solutions to sustainably meet aging patients' needs.
Visit Member Website